Weakening credit scores and rising delinquency may be warning signs of undiagnosed memory disorders

In the years prior to an Alzheimer's disease or other memory disorder diagnosis, credit scores begin to weaken and payment delinquency begins to increase, concludes new research led by Georgetown University. The findings show consistent deterioration in these financial outcomes over the quarters leading up to diagnosis. The findings also show that credit card and mortgage delinquencies, specifically, both increase substantially prior to diagnosis. 

The research was released today by the Federal Reserve Bank of New York (FRBNY). ("The Financial Consequences of Undiagnosed Memory Disorders").

Most memory disorders aren't diagnosed until symptoms are severe, yet, given the progressive nature of disease, cognitive decline usually starts many years prior. The earliest changes in cognition might not be noticeable by family members and friends, but may be quietly compromising financial decision-making." 

Carole Roan Gresenz, PhD, health economist and study's lead researcher, professor in Georgetown's School of Health and McCourt School of Public Policy

For the study, Gresenz teamed up with collaborators from Georgetown, including a neurologist who specializes in memory disorders as well as researchers at the FRBNY. They examined the effect of undiagnosed memory disorders on credit outcomes using nationally representative credit reporting data merged with Medicare data (all anonymized). Credit cards and mortgages are the primary components of debt among those 70 years and older. 

According to Gresenz, increased credit card delinquency was observed more than five years prior to diagnosis, while mortgage delinquency was seen three years prior. 

"The results are striking in their clarity and consistency," she added. "The financial decline we observe mirrors the cognitive decline that these individuals are experiencing: credit scores consistently decline, quarter by quarter, and probability of delinquency consistently increases as diagnosis approaches." 

The work builds on previous research conducted by Gresenz. That work, which used survey data on roughly 10,000 households, showed that prior to an Alzheimer's diagnosis, a person in the early stages of the disease faces a heightened risk of adverse financial outcomes -; a likely consequence of compromised decision-making when managing money and financial exploitation by others. The research was published in 2019 in the journal Health Economics.

Gresenz added, "In addition to the human toll, a diagnosis of this type can be financially disruptive to families and exacerbated by the harmful financial effects of undiagnosed memory disorders. Our findings substantiate the possible utility of credit reporting data for facilitating early identification of those at risk for memory disorders."

In addition to Gresenz, authors include Jean M. Mitchell and R. Scott Turner of Georgetown and Belicia Rodriguez and Wilbert van der Klaauw‖ of the FRBNY. The authors report having no personal financial interests related to the study.

The research was supported by the National Institute on Aging of the National Institutes of Health (R56AGO53272 and R01AG080623). The content of and views expressed do not necessarily represent the official views of the Federal Reserve Bank of New York or the Federal Reserve System or the National Institutes of Health.

Source:
Journal reference:

Gresenz, C. R., et al. (2019). Effect of early‐stage Alzheimer’s disease on household financial outcomes. Health Economics. doi.org/10.1002/hec.3962.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibiotic activity altered by interaction with nanoplastics, new research shows